Metagenomi
Emma Cheng is a Senior Scientist at Metagenomi since January 2022, with extensive experience in the biotechnology field. Prior roles include Manufacturing Lead at Sangamo Therapeutics, Inc. and Operation Manufacturing Lead at Hitachi Chemical Advanced Therapeutics Solutions, LLC, where responsibilities encompassed planning therapeutics projects, troubleshooting analytical methods, and enhancing manufacturing processes. Emma has a strong background in clinical trial support and cell culture processing, as evidenced by positions as Manufacturing Associate I at Hitachi and Process Development Engineer at Phoenix Pharmaceuticals, Inc. Emma holds a Doctor of Philosophy in Bioengineering and Biomedical Engineering, as well as Master's and Bachelor's degrees in Creative Science and Engineering, all from Waseda University.
Metagenomi
3 followers
Gene editing is changing the world. Founded by pioneers in the CRISPR/CAS revolution, Metagenomi is discovering the next generation of gene-editing systems for use in treating genetic diseases.